Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer- simulated artificial neural network

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 2, 1998, Pages 146-159

  Cherniak, Robert ^a   Valafar, Homayoun ^b   Morris, Laura C ^a   Valafar, Faramarz ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOPYRANOSYLURONIC ACID; GLUCURONOXYLOMANNAN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; ARTIFICIAL NEURAL NETWORK; BACTERIUM ISOLATION; COMPUTER SIMULATION; CRYPTOCOCCUS NEOFORMANS; FUNGUS IDENTIFICATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS; SERODIAGNOSIS; STRUCTURE ANALYSIS;

BACTERIAL TYPING TECHNIQUES; CARBOHYDRATE SEQUENCE; COMPUTER SIMULATION; CRYPTOCOCCUS NEOFORMANS; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; NEURAL NETWORKS (COMPUTER); POLYSACCHARIDES;

EID: 0031954677     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Akay, M. 1992. Noninvasive diagnosis of coronary artery disease using a neural network algorithm. Biol. Cybern. 67:361-367.
2. Alpsan, D. 1994. Auditory evoked potential classification by unsupervised ART 2-A and supervised fuzzy ARTMAP networks, p. 3512-3515. In Proceedings of IEEE International Conference on Neural Networks, Orlando, Fla. IEEE Neural Network Council, New York, N.Y.
3. Andrea, T. A., and H. Kalayeh. 1991. Applications of neural networks: quantitative structure-activity relationships of dihydrofolate reductase inhibitors. J. Med. Chem. 34:2824-2836.
4. Andreassen, H., H. Bohr, J. Bohr, S. Brunak, T. Bugge, R. M. J. Cotterill, C. Jacobsen, P. kusk, and B. Lautrap. 1990. Analysis of secondary structure of the human immunodeficiency virus proteins by computer modelling based on neural network methods. J. Acquired Immune Defic. Syndr. 3:615-622.
5. Apolloni, B., G. Avanzini, N. Cesa-Bianchi, and G. Ronchini. 1990. Diagnosis of epilepsy via backpropagation, p. 571-574. In Proceedings of the 1990 International Joint Conference on Neural Networks, vol. 2.
6. Armentrout, S. L., J. A. Reggia, and M. Weinrich. 1994. A neural model of cortical map reorganization following a focal lesion. Artif. lntellig. Med. 6:383-400.
7. Asada, N., K. Doi, H. MacMahon, S. M. Montner, M. L. Giger, C. Abe, and Y. Z. Wu. 1990. Potential usefulness of an artificial neural network for differential diagnosis of interstitial lung disease: pilot study. Radiology 177: 857-860.
8. Astion, M. L., and P. Wilding. 1992. The application of backpropagation neural networks to problems in pathology and laboratory medicine. Arch. Pathol. Lab. Med. 116:995-1001.
9. Astion, M. L., and P. Wilding. 1992. Application of neural networks to the interpretation of laboratory data in cancer diagnosis. Clin. Chem. 38:34-38.
10. Avanzolini, G., P. Barbini, and G. Gnudi. 1990. Unsupervised learning and discriminanl analysis applied to identification of high risk postoperative cardiac patients. Int. J. Bio-Med. Comput. 25:207-221.
11. 1H NMR spectroscopy. Carbohydr. Res. 276:365-386.
12. 1H NMR spectroscopy. Carbohydr. Res. 283:95-110.
13. Barski, L. L., R. S. Gaborski, and P. G. Anderson. 1993. A neural network approach to the histogram segmentation of digital radiographic images, p. 375-380. In C. H. Dagli, L. I. Burke, B. R. Fernandez, and J. Ghosh (ed.), Intelligent engineering systems through artificial neural networks. Proceedings of the Artificial Neural Networks in Engineering Conference, vol. 3. ASME Press, New York, N.Y.
14. Baxt, W. G. 1990. Use of an artificial neural network for data analysis in clinical decision-making: the diagnosis of acute coronary occlusion. Neural Comput. 2:480-489.
15. Belay, T., and R. Cherniak. 1995. Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay. Infect. Immun. 63:1810-1819.
16. Belay, T., R. Cherniak, E. B. O'Neill, and T. R. Kozel. 1996. Serotyping of Cryptococcus neoformans by dot enzyme assay. J. Clin. Microbiol. 34:466-470.
17. Belay, T., R. Cherniak, T. R. Kozel, and A. Casadevall. 1997. Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and by dot enzyme assay. Infect. Immun. 65:718-728.
18. Bhattacharjee, A. K., J. E. Bennett, and C. P. J. Glaudemans. 1984. Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6:619-624.
19. Bottone, E. .J., I. F. Salkin, N. J. Hurd, and G. P. Wormser. 1987. Serogroup distribution of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 156:242.
20. Bulmer, G. S., and M. D. Sans. 1968. Cryptococcus neoformans. III. Inhibition of phagocytosis. J. Bacteriol. 95:5-8.
21. Chaka, W., A. F. M. Verheul, V. V. Vaishnav, R. Cherniak, J. Scharringa, J. Verhoef, H. Snippe, and I. M. Hoepelman. 1997. Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect. Immun. 65:272-278.
22. Cherniak, R., L. C. Morris, B. C. Anderson, and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
23. Cherniak, R., L. C. Morris, S. A. Meyer, and T. B. Mitchell. 1992. Glucuronoxylomannan of Cryptococcus neoformans obtained from patients with AIDS. Carbohydr. Res. 249:405-413.
24. 13C nuclear magnetic resonance spectroscopy. Carbohydr. Res. 225:331-337.
25. Coker, R. J. 1992. Cryptococcal infection in AIDS. Int. J. Sex. Transm. Dis. AIDS 3:168-172.
26. Diamond, K. D. 1995. Cryptococcus neoformans, p. 2331-2340. In G. L. Mandell, J. E. Bennett, and R. G. Douglas, Jr. (ed.), Principles and practice of infectious diseases. Churchill Livingstone, New York, N.Y.
27. Dismukes, W. E. 1998. Cryptococcal meningitis in patients with AIDS. J. Infect. Dis. 157:624-628.
28. Dog, Z. M., and J. W. Murphy. 1995. Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63:770-778.
29. Echauz, J., and G. Vachtsevanos. 1994. Neural network detection of antiepileptic drugs from a single EEG trace, p. 346-351. In Proceedings of the IEEE Electro/94 International Conference.
30. Ersoy, O. K., and D. Hong. 1990. Parallel, self-organizing, hierarchical neural networks. IEEE Trans. Neural Netw. 1:167-178.
31. Evans, E. E. 1950. The antigenic composition of Cryptococcus neoformans. 1. A serologic classification by means of the capsular and agglutination reactions. J. Immunol. 64:423-430.
32. Fromtling, R. A., H. J. Shadomy, and E. S. Jacohson. 1982. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79:23-29.
33. Ikeda, R., T. Shinoda, Y. Fukazawa, and L. Kaufman. 1982. Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates. J. Clin. Microbiol. 16:22-29.
34. Kaufman, L., and E. Reiss. 1992. Serodiagnosis of fungal diseases, p. 507-528. In N. R. Rose, E. C. de Macario, J. L. Fahey, H. Friedman, and G. M. Penn (ed.), Manual of clinical laboratory immunology, 4th ed. American Society for Microbiology, Washington, D.C.
35. Kovacs, J. A., A. A. Kovacs, M. Polis, W. C. Wright, V. J. Gill, C. U. Tuazon, E. P. Gelmann, H. C. Lane, R. Longfield, G. Overturf, A. M. Macher, A. S. Fauci, J. E. Parrillo, J. E. Bennett, and H. Masur. 1985. Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103:533-538.
36. Kozel, T. R., and E. C. Gotschlich. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast macrophages. J. Immunol. 129:1675-1680.
37. Kozel, T. R., W. F. Gulley, and J. Cazin, Jr. 1977. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect. Immun. 18:701-707.
38. Kwon-Chung, K.-J., and J. E. Bennett. 1992. Medical mycology, p. 397-446. Lea and Febiger, Malvern, Pa.
39. Kwon-Chung, K. J., I. Polacheck, and J. E. Bennett. 1982. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J. Clin. Microbiol. 15:535-537.
40. Kwong-Chung, K. J., A. Varma, and D. H. Howard. 1990. Ecology of Cryptococcus neoformans and prevalence of its two varieties in AIDS and non-AIDS associated Cryptococcosis, p. 103-113. In H. V. Bossche and D. W. R. Mackenzie (ed.), Mycoses in AIDS patients. Plenum Press, New York, N.Y.
41. Levitz, S. M. 1991. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev. Infect. Dis. 13:1163-1169.
42. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62:1975-1981.
43. 1H-NMR spectra of complex oligosaccharides with artificial neural networks. Science 251:542-544.
44. Mitchell, T. G., and J. R. Perfect. 1995. Cryptococcosis in the era of AIDS -100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8:515-548.
45. Murphy, J. W. 1989. Immunoregulation in Cryptococcosis, p. 319-344. In E. Kurstak (ed.), Immunology of fungal infections. Marcel Dekker, Inc., New York, N.Y.
46. Orendi, J. M., H. S. L. M. Nottet, M. Visser, A. F. M. Verheul, H. Snippe, and J. Verhoef. 1994. Enhancement of HIV-1 replication in peripheral blood mononuclear cells by Cryptococcus neoformans is monocyte-dependent but tumor necrosis factor-independent. AIDS 8:423-429.
47. Pettoello-Mantovani, M., A. Casadevall, T. R. Kollmann, A. Rubinstein, and H. Goldstein. 1992. Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans. Lancet 339:21-23.
48. Pinner, R. W., R. A. Hajjeh, and W. G. Powderly. 1995. Prospects for preventing Cryptococcosis in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 21:S103-S107.
49. Powell, D. A., V. Turula, J. A. de Haseth, H. van Halbeek, and B. Meyer. 1994. Sulfate detection in glycoprotein-derived oligosaccharides by artificial neural network analysis of Fourier-transform infrared spectra. Anal. Biochem. 220:20-27.
50. 1H-NMR spectra. Nat. Struct. Biol. 1:217-218.
51. Rinaldi, M. G., D. J. Drutz, A. Howell, M. A. Sande, C. B. Wofsy, and W. K. Hadley. 1986. Serotypes of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 153:642.
52. Rippon, J. W. 1988. Medical mycology: the pathogenic fungi and the pathogenic actinomycetes, 3rd ed., p. 582-609. W. B. Saunders Co., Philadelphia, Pa.
53. Rumelhart, D. E., and J. L. McClelland. 1987. Parallel distributed processing: explorations in the microstructure of cognition, vol. 1 and 2. MIT Press, Cambridge, Mass.
54. Sellers, J., W. York, P. Albersheim, A. Darvill, and B. Meyer. 1990. Identification of the mass spectra of partially methylated alditol acetates by artificial neural networks. Carbohydr. Res. 207:C1-C5.
55. Shadmehr, R., and D. Z. D'Argcnio. 1990. A neural network for nonlinear Bayesian estimation in drug therapy. Neural Comput. 2:216-225.
56. 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy. Carbohydr. Res. 301:33-40.
57. Shimizu, R. Y., D. H. Howard, and M. N. Clancy. 1986. The variety of Cryptococcus neoformans in patients with AIDS. J. Infect. Dis. 154:1042.
58. 13C-NMR spectra of the de-O-acetylated glucuronoxylomannan from Cryptococcus neoformans serotype B. Carbohydr. Res. 221: 259-268.
59. Skelton, M. A., R. Cherniak, L. Poppe, and H. van Halbeek. 1991. Structure of the de-O-acetylated glucuronoxylomannan from Cryptococcus neoformans serotype D, as determined by 2D NMR spectroscopy. Magn. Reson. Chem. 29:786-793.
60. Sundstrom, J. B., and R. Cherniak. 1994. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62:1507-1512.
61. 1H NMR spectra of sugar alditols using a neural network. J. Magn. Reson. 84:212-217.
62. 13C NMR spectroscopy. Carbohydr. Res. 233:205-218.
63. Turner, S. H., and R. Cherniak. 1991. Multiplicity in the structure of the glucuronoxylomannan of Cryptococcus neoformans. NATO ASI (Adv. Sci. Inst.) Ser. Ser. H 53:123-142.
64. Valafar, F., H. Valafar, O. K. Ersoy, and R. J. Schwartz. 1995. Comparative studies of two neural network architectures for modeling of human speech production, p. 2056-2059. In Proceedings of the International Conference on Neural Networks, vol. 4.
65. 1H-NMR spectroscopy. Biochem. Soc. Trans. 12:601-605.
66. 1H-nuclear magnetic resonance spectroscopy as a tool in the structural analysis of carbohydrates related to glyeoproteins. Adv. Carbohydr. Chem. Biochem. 41:209-374.
67. Welisk, R. M., E. T. Starcher, and J. W. Curran. 1987. Opportunistic disease reported in AIDS patients: frequencies, associations and trends. AIDS 1:175-182.
68. Wilson, D. E., J. E. Bennett, and J. W. Bailey. 1968. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127:820-823.